Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,56118,580 of 20,252 grants

Completed NON-SBIR/STTR RPGS
SMARCB1 regulated SWI/SNF complex function in Malignant Rhabdoid Tumors
NATIONAL CANCER INSTITUTE Dartmouth College United States 2021 – 2026

PROJECT SUMMARY A research program will be undertaken to study SMARCB1-regulated SWI/SNF complex function in malignant rhabdoid tumors. Over the past few years, major cancer genome...

$3.68M
USD
Completed NON-SBIR/STTR RPGS
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Immunotherapy induces durable remissions in a subset of patients with highly mutated cancers. However, most cancers are modestly mutated and fail to respon...

$5.18M
USD
Completed TRAINING, INDIVIDUAL
Defining the regulation of UHRF1 and DNMT1 for maintenance of the epigenome
NATIONAL CANCER INSTITUTE Van Andel Research Institute United States 2021 – 2024

PROJECT SUMMARY In multicellular organisms, methylation of DNA on the 5’ carbon of cytosine helps ensure proper gene expression. Methylation occurs symmetrically on both DNA strand...

$698K
USD
Completed NON-SBIR/STTR RPGS
Modeling cancer risk and environmental and socio-spatial exposures using residential histories
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2025

In many studies on the risk of disease, investigators analyze the spatial patterns of health outcomes and evaluate residential environmental exposures at the time of study enrollme...

$3.27M
USD
Completed NON-SBIR/STTR RPGS
Epigenetic Control and Genome Organization
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

OVERALL PROGRAM SUMMARY Gary Stein and Janet Stein, Program Directors Our Program Project is a thematically, experimentally and operationally integrated multidisciplinary team appr...

$17.35M
USD
Completed NON-SBIR/STTR RPGS
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

PROJECT 1 | SUMMARY Mechanisms underlying the epithelial to mesenchymal transition (EMT)—a normal developmental process and an early event at the onset of epithelium-derived cancer...

Completed NON-SBIR/STTR RPGS
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

PROJECT 2: SUMMARY Breast cancer (BCa) ranks among the leading causes of cancer death in women worldwide. Estrogen Receptor alpha positive tumors (ER+) are the most common subtype...

Completed NON-SBIR/STTR RPGS
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

SUMMARY Long non-coding RNAs (lncRNAs) are epigenetic regulators of the chromatin organization supporting cancer cell activities. There is a gap in the literature identifying the c...

Completed NON-SBIR/STTR RPGS
Administration and Coordination Core
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

SUMMARY/ABSTRACT Administration and Coordination Core Gary Stein, Core Leader; Janet Stein, Co-Leader The Administration and Coordination Core will provide leadership, and administ...

Completed NON-SBIR/STTR RPGS
Experimental Integration, Design and Analysis Core
NATIONAL CANCER INSTITUTE University of Vermont & St Agric College United States 2021 – 2026

Summary: Experimental Integration, Design and Analysis Core The Experimental Integration, Design, and Analysis (EIDA) Core is an essential component of the program project that is...

Completed NON-SBIR/STTR RPGS
Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Summary Therapeutic resistance and tumor relapse present as major barriers to achieving a definitive cure for cancer. This challenge is especially relevant for patients with pancre...

$4.51M
USD
Completed NON-SBIR/STTR RPGS
Stem Cell-based Platform for Targeted Enzyme/Prodrug Therapy of Recurrent Ovarian Cancer
NATIONAL CANCER INSTITUTE Rutgers, the State University of N.J United States 2021 – 2023

Project Summary: Ovarian cancer (OC) is associated with the highest mortality rate of all gynecologic malignancies in the United States. The low rate of survival is mainly due to t...

$3.82M
USD
Completed OTHER RESEARCH-RELATED
Regulation and function of exosomal cargo loading in cancer progression
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2022

Regulation and function of exosomal cargo loading in cancer progression Exosomes are 50-150 nm, endosome-derived, extracellular vesicles that are secreted by most cells. The exosom...

$1.78M
USD
Completed SBIR-STTR RPGS
Immune Biomarker Assessment and Manufacturing Development for SQ3370-001, a first-in-human phase I dose-escalation clinical trial to test a novel treatment against advanced solid tumors
NATIONAL CANCER INSTITUTE Shasqi, Inc United States 2021 – 2024

Abstract In 2018, the global incidence of new cancer diagnoses was estimated at over 18 million cases, and cancer- related deaths were estimated at over 9.6 million. Of these cases...

$8.01M
USD
Completed NON-SBIR/STTR RPGS
Changing Contraceptive Patterns and Ovarian Cancer Risk
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2026

ABSTRACT Contraceptive patterns are changing and the implications for ovarian cancer risk are unknown. Oral contraceptives (OCs), which are an established protective factor for ova...

$5.66M
USD
Completed NON-SBIR/STTR RPGS
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY / ABSTRACT: Nanoparticles (NPs) hold great promise for delivering more effective and safer cancer treatment than the small molecule drugs that are commonly used. Th...

$5.45M
USD
Completed NON-SBIR/STTR RPGS
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY Relapse is the major cause of cancer related mortality in children with leukemia. Despite improvements in overall survival for children with B-cell progenitor acute...

$6.04M
USD
Completed TRAINING, INDIVIDUAL
Mechanistic Studies of a Novel Vulnerability in Pediatric Cancer
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital Gr... United States 2021 – 2023

Project Abstract Rhabdoid tumors (RT) are aggressive and lethal cancers that occur in young children. These tumors are resistant to chemotherapy and have a five-year survival rate...

$452.5K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Regulation and Requirement of the NAD salvage pathway in CD8+ T Cell Exhaustion
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

Project Summary The development of checkpoint based cancer immunotherapy has revolutionized cancer treatment in the last decade. Although many otherwise untreatable patients have s...

$467.5K
USD
Completed TRAINING, INDIVIDUAL
Mechanisms regulating the formation of a pro-metastatic niche and tumor cell dormancy in the liver
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2023

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is the third-leading cause of cancer-related deaths in the United States. For patients with PDAC, metastasis is the major cause of...

$395.1K
USD